Related Experiment Video
Updated: Sep 15, 2025

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
The Emerging Role of CCL17 in the Immunologic Regulation of Inflammatory Bowel Disease
Cong Zhang1, Yong-Wen Ouyang1, Hui-Xin He1
1Department of Gastroenterology, The First People's Hospital of Foshan, Foshan, People's Republic of China.
Chemokine (C-C) ligand 17 (CCL17) is a key molecule that mediates immune cell migration and inflammation. As a ligand for the type 4 C-C chemokine receptor (CCR4), CCL17 mainly affects T cells, but also influences other cell types, suggesting a broader role in immune regulation. This review comprehensively demonstrates the molecular structure and function of CCL17, its interaction with CCR4, and its involvement in the pathogenesis of inflammatory bowel disease (IBD). Additionally, we also discuss how CCL17 regulates the behavior of various immune cells, including T cells, dendritic cells, monocytes/macrophages, eosinophils, neutrophils, and fibroblasts, highlighting its involvement in the pathogenesis of IBD and its potential contribution to IBD-related colon cancer. In conclusion, this review emphasizes the important role of CCL17 in the pathogenesis of IBD and its potential as a therapeutic target.
Chemokine (C-C) ligand 17 (CCL17) is a key molecule that mediates immune cell migration and inflammation. As a ligand for the type 4 C-C chemokine receptor (CCR4), CCL17 mainly affects T cells, but also influences other cell types, suggesting a broader role in immune regulation. This review comprehensively demonstrates the molecular structure and function of CCL17, its interaction with CCR4, and its involvement in the pathogenesis of inflammatory bowel disease (IBD). Additionally, we also discuss how CCL17 regulates the behavior of various immune cells, including T cells, dendritic cells, monocytes/macrophages, eosinophils, neutrophils, and fibroblasts, highlighting its involvement in the pathogenesis of IBD and its potential contribution to IBD-related colon cancer. In conclusion, this review emphasizes the important role of CCL17 in the pathogenesis of IBD and its potential as a therapeutic target.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

